News and Trends 22 Jan 2018 Abcam Will Start Selling Over 700 Antibodies from Roche …to over 500 other antibodies. And, as Spring continues developing new antibodies, the antibody seller will have the rights to all products that Roche decides to commercialize. For its part,… January 22, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Sponsored 27 Nov 2019 How to Address the Challenges of Biologics Discovery and Development …key market players enter the field, competition is increasing. In recent years, the biologics industry has become more versatile and has moved from being primarily antibody-focused to including other modalities,… November 27, 2019 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 12 Dec 2022 OSE Immunotherapeutics announces latest acute lymphoblastic leukemia data …to its dual mode of action comprising both antibody-dependent cellular phagocytosis induction and IL-7R-pathway blockade, OSE-127 may represent a promising novel immunotherapy option for ALL patients, including cases with dysregulated… December 12, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 6 Mar 2017 How did this Biotech seal a €1B Deal with AstraZeneca? The CEO Explains …use bicyclic peptides to guide toxins in an approach similar to antibody-drug conjugates (ADCs); and they stand to outperform their antibody-guided counterparts. Kevin Lee, CEO of Bicycle Therapeutics, sat down… March 6, 2017 - 7 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 29 May 2020 Argenx Follows up Phase III Success with Giant €785M Global Offering …III trial results earlier this week, where its lead candidate antibody drug, efgartigimod, improved motor symptoms of patients with the chronic autoimmune disease myasthenia gravis. Argenx is listed on the… May 29, 2020 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 26 Dec 2017 Interviews, Reviews and Tops: Our Best Biotech Articles from 2017 …women calling the shots in European biotech. And if you can’t get enough of leading ladies, check out our list of biotech’s top women entrepreneurs. https://www.labiotech.eu/best-biotech/ Cambridge Antibody Technology, Solexa,… December 26, 2017 - 6 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
In Depth 19 Jul 2022 The biggest Asia-Pacific biotech investments in June 2022 …using artificial intelligence (AI) and robotics to automate many research techniques including antibody selection, cell line development and molecular screening. “The global life sciences automation industry has significant growth potential,”… July 19, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Startup Scout 21 Nov 2022 Osivax is designing future-proof influenza and Covid vaccines …T cells must often be tested in tissue samples. “If you can get an antibody-based vaccine that protects well and neutralizes the virus, you wouldn’t need to care that much… November 21, 2022 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 25 Jan 2017 Novartis Relies on Biotech to keep up its Solid Financial Performance …($48.5B) in net sales and its therapeutic antibody for psoriasis, Cosentyx (secukinumab), becoming a blockbuster. The Swiss pharma is suffering competition from generics, but it expects these numbers to remain… January 25, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 7 Jan 2019 15 European Biotech Companies to Watch in 2019 …phase I/II trial earlier this month. The Dutch company has a unique spin on antibody technology, taking inspiration from llamas, whose antibodies can recognize very different targets as compared to… January 7, 2019 - 9 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 3 Apr 2019 €21M Series A to Finance Belgian Biotech’s Regenerative Antibodies The Belgian biotech AgomAb has raised €21M and partnered with the Dutch biotech argenx to develop antibody treatments that could regenerate damaged tissue. The round was led by the Belgian… April 3, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 4 Sep 2018 The EMA Approves the First Nanobody from Ablynx …nanobody — a single-domain antibody inspired by those of llamas and camels that combines the specificity of a full antibody with the advantages of having a significantly smaller size. After… September 4, 2018 - 2 minutesmins - By Editorial Team Share WhatsApp Twitter Linkedin Email